Authors:
Kalergis, AM
Boucheron, N
Doucey, MA
Palmieri, E
Goyarts, EC
Vegh, Z
Luescher, IF
Nathenson, SG
Citation: Am. Kalergis et al., Efficient cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex, NAT IMMUNOL, 2(3), 2001, pp. 229-234
Citation: Xw. Zhang et al., Crystallization and preliminary X-ray analysis of the complex between human CTLA-4 and B7-2, ACT CRYST D, 57, 2001, pp. 898-899
Authors:
Reddy, B
Gupta, S
Chuzhin, Y
Kalergis, AM
Budhai, L
Zhang, ML
Droguett, G
Horwitz, MS
Chowdhury, JR
Nathenson, SG
Davidson, A
Citation: B. Reddy et al., The effect of CD28/B7 blockade on alloreactive T and B cells after liver cell transplantation, TRANSPLANT, 71(6), 2001, pp. 801-811
Authors:
Honda, S
Zhang, WJ
Kalergis, AM
DiLorenzo, TP
Wang, FM
Nathenson, SG
Citation: S. Honda et al., Hapten addition to an MHC class I-binding peptide causes substantial adjustments of the TCR structure of the responding CD8(+) T cells, J IMMUNOL, 167(8), 2001, pp. 4276-4285
Authors:
Zhang, WJ
Honda, S
Wang, FM
DiLorenzo, TP
Kalergis, AM
Ostrov, DA
Nathenson, SG
Citation: Wj. Zhang et al., Immunobiological analysis of TCR single-chain transgenic mice reveals new possibilities for interaction between CDR3 alpha and an antigenic peptide bound to MHC class I, J IMMUNOL, 167(8), 2001, pp. 4396-4404
Authors:
Thomson, CT
Kalergis, AM
Sacchettini, JC
Nathenson, SG
Citation: Ct. Thomson et al., A structural difference limited to one residue of the antigenic peptide can profoundly alter the biological outcome of the TCR-peptide/MHC class I interaction, J IMMUNOL, 166(6), 2001, pp. 3994-3997
Authors:
Serreze, DV
Johnson, EA
Chapman, HD
Graser, RT
Marron, MP
DiLorenzo, TP
Silveira, P
Yoshimura, Y
Nathenson, SG
Joyce, S
Citation: Dv. Serreze et al., Autoreactive diabetogenic T-cells in NOD mice can efficiently expand from a greatly reduced precursor pool, DIABETES, 50(9), 2001, pp. 1992-2000
Authors:
Melian, A
Watts, GFM
Shamshiev, A
De Libero, G
Clatworthy, A
Vincent, M
Brenner, MB
Behar, S
Niazi, K
Modlin, RL
Almo, S
Ostrov, D
Nathenson, SG
Porcelli, SA
Citation: A. Melian et al., Molecular recognition of human CD1b antigen complexes: Evidence for a common pattern of interaction with alpha beta TCRs, J IMMUNOL, 165(8), 2000, pp. 4494-4504
Citation: Am. Kalergis et Sg. Nathenson, Altered peptide ligand-mediated TCR antagonism can be modulated by a change in a single amino acid residue within the CDR3 beta of an MHC class I-Restricted TCR, J IMMUNOL, 165(1), 2000, pp. 280-285
Authors:
Graser, RT
DiLorenzo, TP
Wang, FM
Christianson, GJ
Chapman, HD
Roopenian, DC
Nathenson, SG
Serreze, DV
Citation: Rt. Graser et al., Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions, J IMMUNOL, 164(7), 2000, pp. 3913-3918
Authors:
Kalergis, AM
Goyarts, EC
Palmieri, E
Honda, S
Zhang, WJ
Nathenson, SG
Citation: Am. Kalergis et al., A simplified procedure for the preparation of MHC/peptide tetramers: chemical biotinylation of an unpaired cysteine engineered at the C-terminus of MHC-I, J IMMUNOL M, 234(1-2), 2000, pp. 61-70
Citation: H. Horig et al., Binding of longer peptides to the H-2K(b) heterodimer is restricted to peptides extended at their C terminus: Refinement of the inherent MHC class I peptide binding criteria, J IMMUNOL, 163(8), 1999, pp. 4434-4441
Authors:
Kalergis, AM
Ono, T
Wang, FM
DiLorenzo, TP
Honda, S
Nathenson, SG
Citation: Am. Kalergis et al., Single amino acid replacements in an antigenic peptide are sufficient to alter the TCR V beta repertoire of the responding CD8(+) cytotoxic lymphocyte population, J IMMUNOL, 162(12), 1999, pp. 7263-7270